An article published by Inside Health Policy featured extensive commentary from Senior Director of ML Strategies Aaron Josephson on priorities for the Senate Health, Education, Labor and Pensions (HELP) Committee following the 2020 Presidential election. Mr. Josephson projected a continued focus on COVID-19 response and relief legislation regardless of the election’s outcome, as well as on U.S. Food and Drug Administration (FDA) user fee reauthorizations. In addition, Mintz Member Joanne Hawana was quoted on the future of drug user fees.

Source

Inside Health Policy